Literature DB >> 624179

Mitochondrial fraction of serum glutamic-oxaloacetic transaminase in Duchenne muscular dystrophy.

I Matsuda, S Miyoshino, T Miike, N Nagata, H Tamari, N Taniguchi, H Ohno, H Watanabe.   

Abstract

The mitochondrial fraction of serum glutamic-oxaloacetic transaminase was measured in the serum of 50 patients with Duchenne muscular dystrophy by an immunoadsorbent method. The enzyme activities in patients in the early, midstage, and late stages of the disease and controls were 21.8 +/- 7.4 (N=9), 12.2 +/- 3.7 (N=38), 6.4 +/- 1.2 (N=3) and 4.2 +/1 1.2 units/ml (N=15), respectively. The enzyme level in the early stage was significantly elevated (p less than 0.01, vs. control, p less than 0.05 vs. mid stage). As the disease progressed, the levels gradually declined, but mid-stage values were still higher than the late stage (p less than 0.01) or control values (p less than 0.01). In the late stage, enzyme activity was within the control range.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 624179     DOI: 10.1016/0009-8981(78)90111-0

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  2 in total

1.  Alanine and aspartate aminotransferases in normal and denervated skeletal muscle.

Authors:  K Asotra; S Asotra
Journal:  Experientia       Date:  1984-09-15

2.  Glutamate oxaloacetate transaminase (GOT) in the dy2J genotypes of C57BL/6J mice: possible involvement of regulatory defect in muscular dystrophy.

Authors:  S M Singh; A Phillips; C H Wang
Journal:  Experientia       Date:  1982-08-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.